168 related articles for article (PubMed ID: 26722543)
1. Expression of EphA2 protein is positively associated with age, tumor size and Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang L; Hu H; Tian F; Zhou W; Zhou S; Wang J
Int J Clin Exp Pathol; 2015; 8(10):13374-80. PubMed ID: 26722543
[TBL] [Abstract][Full Text] [Related]
2. Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang X; Liu Y; Cao G; Zhang X; Xu H; Xu H; Wang J
Int J Clin Exp Pathol; 2015; 8(6):6821-7. PubMed ID: 26261568
[TBL] [Abstract][Full Text] [Related]
3. Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.
Herrem CJ; Tatsumi T; Olson KS; Shirai K; Finke JH; Bukowski RM; Zhou M; Richmond AL; Derweesh I; Kinch MS; Storkus WJ
Clin Cancer Res; 2005 Jan; 11(1):226-31. PubMed ID: 15671550
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of ephrin type-A2 receptor and Ki-67 in renal cell carcinoma patients: An Immunohistochemical and Bioinformatical Approach; A STROBE - compliant article.
Talaat IM; Okap IS; Abou Youssif TM; Hachim IY; Hachim MY; Sheikh SME
Medicine (Baltimore); 2020 May; 99(19):e20191. PubMed ID: 32384514
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of EphA5 is associated with Fuhrman nuclear grade and pathological tumour stage in ccRCC.
Wang X; Xu H; Wu Z; Chen X; Wang J
Int J Exp Pathol; 2017 Feb; 98(1):34-39. PubMed ID: 28421649
[TBL] [Abstract][Full Text] [Related]
6. [Expression of EphA2 and EphrinA1 in human renal cell carcinoma and its relationship with angiogenesis].
Xu JS; Zhang JX; Geng TH; Wang YF; Wang XL; Zuo LF
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):438-41. PubMed ID: 19950554
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas.
Zhou S; Wang L; Li G; Zhang Z; Wang J
Int J Clin Exp Pathol; 2014; 7(7):4254-60. PubMed ID: 25120806
[TBL] [Abstract][Full Text] [Related]
8. Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma.
Toma MI; Erdmann K; Diezel M; Meinhardt M; Zastrow S; Fuessel S; Wirth MP; Baretton GB
PLoS One; 2014; 9(7):e102262. PubMed ID: 25025847
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
10. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma.
Deng Q; Wang Z; Wang L; Zhang L; Xiang X; Wang Z; Chong T
Jpn J Clin Oncol; 2013 Dec; 43(12):1261-8. PubMed ID: 24186908
[TBL] [Abstract][Full Text] [Related]
11. The expression of insulin-like growth factor-I receptor correlates with Fuhrman grading of renal cell carcinomas.
Ahmad N; Keehn CA; Coppola D
Hum Pathol; 2004 Sep; 35(9):1132-6. PubMed ID: 15343516
[TBL] [Abstract][Full Text] [Related]
12. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma.
Chuang ST; Patton KT; Schafernak KT; Papavero V; Lin F; Baxter RC; Teh BT; Yang XJ
J Urol; 2008 Feb; 179(2):445-9. PubMed ID: 18076934
[TBL] [Abstract][Full Text] [Related]
13. Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma.
Tatsumi T; Herrem CJ; Olson WC; Finke JH; Bukowski RM; Kinch MS; Ranieri E; Storkus WJ
Cancer Res; 2003 Aug; 63(15):4481-9. PubMed ID: 12907621
[TBL] [Abstract][Full Text] [Related]
14. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
15. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
16. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
[TBL] [Abstract][Full Text] [Related]
17. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
Lee C; Park JW; Suh JH; Moon KC
Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
19. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
